Table 4 |
|||
|
Molecular basis of low penetrance retinoblastoma |
|||
|
Type of mutation |
Number of LP families |
Description of mutations and frequency a |
Functional consequences |
|
|
|||
|
Regulatory |
3 |
-198G>A (1/2) -188G>T (1/2) -149G>C (1/1) |
Low expression of normal Rb protein |
|
MS point mutations |
12 |
R661W (8/20) C712R (2/5) W563L (1/1) R787Q (1/1) |
Partial inactivation of Rb protein |
|
Inframe deletion |
3 |
Del:N480 (1/1) Del:E04 Del: E24–25 |
Partial inactivation of Rb protein |
|
Splicing |
10 |
607+1G>T (4/11) 862-10T>C (1/1) 539+1delG, del E05 (1/1) 2325+5G>A, del E:22 (1/1) Q443P/del:E13 (1/1) V654L/splice (1/2) E732E/del E:21(1/2) |
Alternative splicing and/or unessential exon skipping resulting in low expression or partial inactivation of Rb protein |
|
NS point mutation |
1 |
Q675X (1/1) |
Alternative splicing involving the stop codon |
|
|
|||
|
aRatio of mutations found in LP families vs. all mutations in the database is shown in brackets |
|||
|
Valverde et al. BMC Genetics 2005 6:53 doi:10.1186/1471-2156-6-53 |
|||